| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 30 |
| 1 | PANTOPRAZOLE | 17 |
| 2 | ASPIRIN | 11 |
| 3 | ASPIRIN 325 MG | 11 |
| 4 | ASPIRIN 81 MG | 11 |
| 5 | LISINOPRIL | 10 |
| 6 | METHOTREXATE | 10 |
| 7 | METHOTREXATE SODIUM | 10 |
| 8 | ACETAMINOPHEN | 9 |
| 9 | ALLOPURINOL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RYDAPT | 8 | 0.0041 |
| 1 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 2 | MITOXANTRONE HYDROCHLORIDE | 8 | 0.0013 |
| 3 | NALOXONE HCL | 1 | 0.0012 |
| 4 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 6 | CLADRIBINE | 8 | 0.0008 |
| 7 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 8 | SUCROFERRIC OXYHYDROXIDE | 2 | 0.0007 |
| 9 | GLYCOPYRRONIUM | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 18 |
| 2 | Benzodiazepine [EPC] | 13 |
| 3 | Kinase Inhibitor [EPC] | 13 |
| 4 | Opioid Agonist [EPC] | 13 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 7 | Purine Antimetabolite [EPC] | 11 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphate Binder [EPC] | 2 | 0.0007 |
| 1 | GLP-2 Analog [EPC] | 7 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 4 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 7 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |